Phosphatidylserine-exposing extracellular vesicles in body fluids are an innate defence against apoptotic mimicry viral pathogens
Related Experiment Video
Updated: Jun 29, 2025

Quantification of Efferocytosis by Single-cell Fluorescence Microscopy
Published on: August 18, 2018
Rüdiger Groß1, Hanna Reßin1, Pascal von Maltitz1
1Institute of Molecular Virology, Ulm University Medical Center, Ulm, Germany.
Abstract:
Some viruses are rarely transmitted orally or sexually despite their presence in saliva, breast milk, or semen. We previously identified that extracellular vesicles (EVs) in semen and saliva inhibit Zika virus infection. However, the antiviral spectrum and underlying mechanism remained unclear. Here we applied lipidomics and flow cytometry to show that these EVs expose phosphatidylserine (PS). By blocking PS receptors, targeted by Zika virus in the process of apoptotic mimicry, they interfere with viral attachment and entry. Consequently, physiological concentrations of EVs applied in vitro efficiently inhibited infection by apoptotic mimicry dengue, West Nile, Chikungunya, Ebola and vesicular stomatitis viruses, but not severe acute respiratory syndrome coronavirus 2, human immunodeficiency virus 1, hepatitis C virus and herpesviruses that use other entry receptors. Our results identify the role of PS-rich EVs in body fluids in innate defence against infection via viral apoptotic mimicries, explaining why these viruses are primarily transmitted via PS-EV-deficient blood or blood-ingesting arthropods rather than direct human-to-human contact.
Insights
Extracellular vesicles (EVs) in body fluids inhibit viruses like Dengue and Ebola by exposing phosphatidylserine (PS). This PS prevents viruses using apoptotic mimicry from attaching and entering cells, limiting their spread.
Area of Science:
- Virology
- Immunology
- Cell Biology
Background:
- Some viruses are rarely transmitted sexually or orally despite presence in bodily fluids.
- Extracellular vesicles (EVs) in saliva and semen were previously found to inhibit Zika virus.
- The antiviral spectrum and mechanism of EVs remained unclear.
Purpose of the Study:
- To investigate the antiviral spectrum of EVs in body fluids.
- To elucidate the mechanism by which EVs inhibit viral infections.
- To understand the role of EVs in innate defense against viral transmission.
Main Methods:
- Lipidomics and flow cytometry were used to analyze EVs.
- In vitro assays were performed using physiological concentrations of EVs.
- Viral entry inhibition was assessed for various viruses.
Main Results:
- EVs in body fluids expose phosphatidylserine (PS).
- PS on EVs blocks viruses that use apoptotic mimicry (e.g., Dengue, Ebola, Zika) by interfering with attachment and entry.
- EVs did not inhibit viruses using different entry receptors (e.g., SARS-CoV-2, HIV-1).
Conclusions:
- PS-rich EVs in body fluids provide innate defense against viruses employing apoptotic mimicry.
- This mechanism explains limited sexual/oral transmission of certain viruses, favoring blood or arthropod transmission routes.
- EVs represent a crucial component of the innate immune system against specific viral pathogens.
Related Concept Videos
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized...
The Extrinsic Apoptotic Pathway
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Intralumenal Vesicles and Multivesicular Bodies
Immune Surveillance by NK Cells and Phagocytes
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...

